SELCIA
LIVE

Serial Number

77915471

Owner

Selcia Limited

Attorney

Rebecca Liebowitz

Filing Date

Jan 20, 2010

Add to watchlist:

No watchlists yet
View on USPTO

SELCIA Trademark

Serial Number: 77915471 • Registration: 4266079

SELCIA is a trademark filed by Selcia Limited on January 20, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Selcia Limited

Fyfield Road
Ongar, Essex CM50GS , GB

Entity Type: 03

Trademark Details

Filing Date

January 20, 2010

Registration Date

January 1, 2013

Published for Opposition

October 16, 2012

Goods & Services

(Based on 44(e) Chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use as pharmaceuticals for the treatment of infectious diseases, and diseases and disorders in the field of oncology, hepatology, nephrology, cardiovascular, vascular, respiratory, serology, immunology, haematology, metabolism, neurology and neurodegeneration, neuropathies, pain, gastrointestinal, dermatology, muscoskeletal, central nervous system, endocrinology, hormonal, psychiatric, dementia, urology, obstetrics and gynaecology, ophthalmology, inflammation, odontology, dentistry, cognition, genetic disorders, cerebrovascular, eating disorders, hearing, hypothalamic and pituitary diseases, and sleep disorders; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use in pharmaceutical research and drug discovery; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations, being clinical candidates for use in pharmaceutical research and drug discovery; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use in hit identification, lead generation, optimisation and development in pharmaceutical research; diagnostic agents, preparations and substances for medical purposes; radiolabelled ligands and isotopically labelled compounds used in screening and diagnostic tests for medical purposes; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use as reference standards of products, impurities and metabolites in pharmaceutical and veterinary industries

(Based on 44(e) Printed matter, namely, leaflets, brochures, labels, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, articles, reports, promotional literature and product guides in the field of science, including chemistry and biology, and in the field of pharmaceutical, medicinal, pesticidal, chemical and laboratory research and development services; presentations in the nature of graphic slides and manuals in the field of science, including chemistry and biology, and in the field of pharmaceutical, medicinal, pesticidal, chemical and laboratory research and development services; printed reports and certificates in the field of pharmaceutical research and development, crop protection and environmental regulatory submissions

(Based on 44(e) Services in the provision of chemical and biological compounds for use in research, development and regulatory studies, namely, wholesale distributorship services of chemical compounds; stock management, in the nature of inventory management of chemical compounds

(Based on 44(e) Synthetic, natural and biological chemicals used in industry and science; synthetic, natural and biological chemicals used in agriculture, except fungicides, herbicides and parasitides; synthetic, natural and biological chemical compounds for use as radiotracers; radiolabelled chemical compounds for use in regulatory, research and scientific studies for research purposes; synthetic, natural and biological chemical compounds with isotopic labels for research purposes; synthetic, natural and biological chemical compounds for research purposes; chemical libraries consisting of chemicals for scientific, research and development use; chemical fragment libraries consisting of chemicals for scientific, research and development use; chemical reagents for non-medical purposes; biochemical and biological preparations for use in industry, science and research, except for medical use; diagnostic preparations for scientific, research and development use; radioactive elements, isotopes and preparations for scientific, research and development use, not including therapeutic or diagnostic use; chemical compounds, natural products and biologicals, namely, chemical compounds, natural products in the nature of plant and fungal extracts, compounds derived from such extracts or plant or fungal derived materials, and biological preparations for use as reference standards of products, impurities and metabolites in agrochemical and chemical industries

(Based on 44(e) Scientific research and development services, and scientific design services in the field of chemical and biological preparation, testing, research and development; scientific consultancy services in the field of chemistry and biology; medicinal chemistry research, development and consultation services; pharmaceutical research services; chemistry research, development and consultation services; synthetic chemistry research, development and consultation services; analytical chemistry research, development and consultation services; natural products chemistry research, development and consultation services; chemical and biological laboratory services; analysis in the field of good laboratory practice; biology research, development and consultation services; cell biology research, development and consultation services; biology research, development and consultation services in lead discovery and optimisation; consultancy services in the field of drug discovery and evaluation; research, development and consultation services in the field of radiolabelling; consultancy services in the field of radiolabelling and radiosynthesis; synthesis and analysis of radiolabelled compounds; research, development and consultation services in the field of stable labelling; research, development and consultation services in the field of fragment based drug discovery, fragment screening and fragment based lead discovery; synthesis and analysis of chemical compounds; provision of analytical chemistry and biology services to support regulatory submissions; provision of certification and analysis of the goods and services of others for regulatory submissions; nuclear magnetic resonance spectroscopy for research, development and laboratory purposes; nuclear magnetic resonance spectroscopy for research, development and laboratory purposes; research, development and consultation services in the field of metabolite synthesis; chemistry and biology services, namely, synthesis of reference standards, process impurities and metabolites; analysis, research and investigation into chemical compounds; analysis, research and investigation into structural elucidation, metabolite identification and spectral interpretation; anti-counterfeiting services for chemical compounds, namely, analysis of chemical and biological compounds for purity measurement; preparation of expert reports and interpretation in the field of chemistry, biology and chemical analysis; services in the provision of information and reports in the field of chemistry, biology and chemical analysis for use in research, development and regulatory studies; scientific data interpretation services; scientific investigation, research, development and analysis in the fields of pharmaceuticals, biotechnology, structural biology, veterinary, animal health, agriculture, pesticides, insecticides, fungicides, herbicides, biocides, food and nutrition, household, personal care, cosmetics and the chemical industry; chemical and biological fragment screening technology research, development and consultation services; electrophoresis research, development and consultation services; capillary electrophoresis research, development and consultation services; chemical and biological screening services for research, development and consultation purposes; fragment based chemical and biological screening services for research, development and consultation purposes; services in the provision of a chemical fragment library, namely, chemical information and materials, and research and development services, provided to research laboratories of others for the design and development of chemical and biological compounds and pharmaceuticals; screening services, namely, development of chemical and biological screens, cell biology and protein expression for research and development purposes; adaptation of technology for the provision of screening data and information; provision of information and data in the field of pharmaceutical research and development; consultancy services in the field of the creation, generation and preparation of research proposals in the field of industrial and scientific research and development; provision of medical chemistry and biology research support; technical support services, namely, providing technical advice; provision of information in the fields of scientific research and design, chemical compounds, medical research, medicinal chemistry, pharmaceutical research, chemistry, synthetic chemistry, analytical chemistry, biology, chemical and biological screening and analysis; provision of reports on good scientific, research and development laboratory practice; computational chemistry research, development and consultation services; informatics services, namely, chemistry and biology informatics and molecular informatics services, namely, data analysis and interpretation; combinatorial chemistry research, development and consultation services; consultancy in relation to all the aforesaid services

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 21, 2023 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 21, 2023 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 21, 2023 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2023 APRE
TEAS SECTION 8 & 9 RECEIVED
Jan 3, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 1, 2022 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jan 14, 2019 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jan 14, 2019 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 14, 2019 APRE
TEAS SECTION 8 RECEIVED
Dec 24, 2018 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 1, 2018 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 10, 2017 TCCA
CORRECTION UNDER SECTION 7 - PROCESSED
May 4, 2013 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 1, 2013 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jan 24, 2013 ES7R
REGISTERED-PRINCIPAL REGISTER
Jan 1, 2013 R.PR
PUBLISHED FOR OPPOSITION
Oct 16, 2012 PUBO
NOTICE OF PUBLICATION
Sep 26, 2012 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 7, 2012 PREV
EXAMINERS AMENDMENT MAILED
Aug 30, 2012 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 29, 2012 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 29, 2012 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 29, 2012 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 19, 2012 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 7, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 23, 2012 TROA
NON-FINAL ACTION MAILED
Feb 7, 2012 CNRT
NON-FINAL ACTION WRITTEN
Feb 7, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 13, 2012 ERFR
FINAL REFUSAL MAILED
Jan 5, 2012 CNFR
FINAL REFUSAL WRITTEN
Jan 5, 2012 CNFR
ASSIGNED TO EXAMINER
Dec 22, 2011 DOCK
AMENDMENT FROM APPLICANT ENTERED
Dec 7, 2011 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2011 CRFA
PAPER RECEIVED
Nov 22, 2011 MAIL
INQUIRY AS TO SUSPENSION MAILED
May 23, 2011 CNSI
SUSPENSION INQUIRY WRITTEN
May 23, 2011 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 5, 2011 RCCK
ASSIGNED TO LIE
May 2, 2011 ALIE
LETTER OF SUSPENSION MAILED
Nov 1, 2010 CNSL
SUSPENSION LETTER WRITTEN
Nov 1, 2010 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2010 TROA
NON-FINAL ACTION MAILED
Apr 26, 2010 CNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2010 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2010 NWOS
NEW APPLICATION ENTERED
Jan 23, 2010 NWAP